Factors for nonadherence to first line art therapy in a cohort of Human Immunodeficiency Virus positive adult patients
DOI:
https://doi.org/10.18203/2349-3933.ijam20195250Keywords:
Alkaline phosphatase, Anti-retroviral therapy, Human immunodeficiency virus, Karnataka state acquired immunodeficiency syndrome prevention societyAbstract
Background: Antiretroviral therapy is one of the reasons for falling trend of HIV epidemic at present. The clinical efficacy, toxicity and reasons for failure of first line ART is understudied. This study aimed to determine the frequency rates and reasons for discontinuation of first line ART in a cohort of HIV positive adult patients.
Methods: Cross sectional study was conducted on 11,968 patients of HIV registered at Victoria Hospital ART centre from 2011 to 2017. Using a structured proforma, relevant information was collected from patients taking first line ART. Descriptive statistics was used for analysing the results obtained.
Results: Total 11,968 HIV patients were registered at ART centre during our study period of which only 4,008 patients were taking ART among them, 167 patients were referred for initiation of 2nd line ART. After evaluation 28 were continued on First line,1 opted out, 20 were transferred out,1 discontinued treatment, 17 died, 14 were lost to follow up, 5 were excluded from the study and only 81 patients were started on second line ART. Failure rate of first line ART in our study was 2.02%. Immunological failure followed by clinical failure were the most common reasons for changeover in this study. Tuberculosis was the most common comorbid disease in this study.
Conclusions: First line ART is very effective and well tolerated and has a low failure rate. Low CD4 count, anaemia, raised ALP, low albumin were among the factors associated with treatment failure. WHO staging did not correlate with the treatment failure, recommended routine viral load monitoring for assessing treatment failure.
References
HIV and AIDS in India [Internet]. AVERT. Avert; 2018. Available at: Https://Www.Avert.Org/Professionals/Hiv-Around-World/Asia-Pacific/India. Accessed on Dec 26, 2018
World Bank Open Data. Literacy rate, adult female (% of females ages 15 and above) Available at: https://data.worldbank.org/. Accessed on Dec 26, 2018.
National AIDS Control Organisation. Annual Report, 2017-2018. Available at: https://www.naco.org/annual-report/2017-2018. Accessed 26 December 2018.
Global HIV and AIDS statistics 2018 fact sheet UNAIDS. Available at: http://www.unaids.org/en/resources/fact-sheet. Accessed on Dec26,2018
Wube M, Tesfaye A, Hawaze S. Antiretroviral therapy regimen change among HIV/AIDS patients in Nekemt Hospital: a primary care Hospital in Oromia Regional State, Ethiopia. J Appl Pharmaceutical Sci. 2013 Aug 1;3(8):36-40.
Yayehirad AM, Mamo WT, Gizachew AT, Tadesse AA. Rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at Debremarkos hospital, Northwest Ethiopia: a retrospective follow up study. J AIDS Clini Res. 2013;4(5).
Aldous JL, Haubrich RH. Defining treatment failure in resource-rich settings. Current Opinion in HIV and AIDS. 2009 Nov;4(6):459-66.
World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva: World Health Organization; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf. Accessed March 20, 2015.
World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach. Geneva: World Health Organization; 2006. Available at: http://www.who.int/hiv/ pub/guidelines/artadultguidelines.pdf. Accessed February 24, 2015.
World Health Organization (WHO). Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2008. 2008:1–77. Available at: https://www.unicef.es/sites/ www.unicef.es/files/200806_TowardsUniversalAccessReport2008_ en.pdf. Accessed December 27, 2015.
Todd J, Grosskurth H, Changalucha J, Obasi A, Mosha F, Balira R, et al. Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infectious Dis. 2006 Feb 1;193(3):458-66.
Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K. Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand. AIDS Res Therapy. 2011 Dec;8(1):42.
Datay MI, Boulle A, Mant D, Yudkin P. Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa. JAIDS . 2010 Aug 15;54(5):489-95.
Ma Y, Zhao D, Yu L, Bulterys M, Robinson ML, Zhao Y, et al. Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China. Clini Infect Dis. 2010 Jan 15;50(2):264-71.
Cadosch D, Bonhoeffer S, Kouyos R. Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV. J Royal Society Interface. 2012 Mar 14;9(74):2309-20.
Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal Infect Dis. 2005 Feb 1;191(3):339-47.
Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, et al. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antiviral therapy. 2007 Jan 1;12(1):83.
Lima DG, de Arruda ÉA, de Lima AJ, Oliveira BE, de França Fonteles MM. Factors determining changes in initial antiretroviral therapy. Revista da Associação Médica Brasileira (English Edition). 2012 Mar 1;58(2):222-8.
Srasuebkul P, Calmy A, Zhou J, Kumarasamy N, Law M, Lim PL. Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD). AIDS Res Therapy. 2007 Dec;4(1):18.
Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, et al. Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One. 2010 Jun 1;5(6):e10490.
Messou E, Anglaret X, Duvignac J, Konan-N'Dri E, Komena E, Gnokoro J, et al. Antiretroviral treatment changes in adults from Cote d'Ivoire: the roles of tuberculosis and pregnancy. AIDS (London, England). 2010 Jan 2;24(1):93-9.
Astiti CI, Sawitri AS, Parwati T. Factors associated to first line antiretroviral therapy (ART) failure among HIV/AIDS patients at Sanglah Hospital, Bali. Public Health Preventive Med Arch. 2017;5(1):4-11.
Singh A, Agarwal A, Chakravarty J. kumari S, Rai M, Sundar S. Predictive markers of failure of first line anti-retroviral treatment in HIV patients in India. J AIDS Clin Res. 2013;4:210.
Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. JAIDS. 2006 Jan 1;41(1):53-8.
Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, et al. The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 2003 Oct 17;17(15):2267-9.
Moeketsi NM. Treatment and regimen change in a cohort of HIV positive patients in anti-retroviral treatment at Tshepang Wellness Clinic, Dr George Mukhari Hospital (Doctoral dissertation, University of Limpopo (Medunsa Campus). 2010;15T11:33-50.
